SCHEMBL3729287

SCHEMBL3729287

O=C1N(Cc2ccc(F)cc2)CCC12CCNCC2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.55
▸ POLB P06746 1/20 0.55
▸ HDAC11 Q96DB2 1/20 0.49
▸ RAB9A P51151 1/20 0.44
▸ CCR3 P51677 1/20 0.44
▸ RIPK1 Q13546 4/20 0.42
▸ TP53 P04637 1/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ HTR2B P41595 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.41
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HCRTR1 O43613 1/20 0.39
▸ HCRTR2 O43614 1/20 0.39
▸ MMP1 P03956 1/20 0.39
▸ MMP13 P45452 1/20 0.39
▸ HDAC1 Q13547 1/20 0.38
▸ AKR1B1 P15121 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2839965 0.99 ALDH1A1 (0.54) ALDH1A1POLBHDAC11RAB9ACCR3
SCHEMBL12447928 0.86 HSD11B1 (0.44) ALDH1A1POLBHDAC11RIPK1MEN1
SCHEMBL20869242 0.85 ALDH1A1 (0.54) ALDH1A1POLBHDAC11RAB9ACCR3
SCHEMBL3723506 0.85 KMT2A (0.55) ALDH1A1CCR3RIPK1SIGMAR1MEN1
Hydrochloric Acid SCHEMBL2334727 0.84 HSD11B1 (0.43) ALDH1A1POLBHDAC11RIPK1MEN1
Hydrochloric Acid SCHEMBL2330803 0.84 KMT2A (0.54) ALDH1A1CCR3RIPK1DRD2HTR2A
SCHEMBL21765292 0.83 USP2 (0.56) ALDH1A1HTR2CMEN1KMT2AHCRTR1
Hydrochloric Acid SCHEMBL21753219 0.82 USP2 (0.54) ALDH1A1HTR2CMEN1KMT2AHCRTR1
SCHEMBL23119109 0.82 HDAC11 (0.48) ALDH1A1POLBHDAC11RAB9ACCR3
SCHEMBL23119144 0.82 HDAC11 (0.48) ALDH1A1POLBHDAC11RAB9ACCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492559-B2 Substituted indole compounds GRUENENTHAL GMBH (DE) 2013-07-23 — — US disclosed
US-8492559-B2 Substituted indole compounds GRUENENTHAL GMBH (DE) 2013-07-23 — — US disclosed
EP-2393812-B1 SUBSTITUTED SPIROAMIDES AS B1R-MODULATORS GRUENENTHAL GMBH (DE) 2013-07-03 — — EP disclosed
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 — — US disclosed
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 — — US disclosed
US-8269000-B2 Substituted pyrimidine and triazine compounds GRUENENTHAL GMBH (DE) 2012-09-18 — — US disclosed
US-8269000-B2 Substituted pyrimidine and triazine compounds GRUENENTHAL GMBH (DE) 2012-09-18 — — US disclosed
EP-2393812-A1 SUBSTITUTED SPIRO-AMIDES AS B1R MODULATORS Grünenthal GmbH (DE) 2011-12-14 — — EP disclosed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 — — US disclosed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 — — US disclosed
US-20100222324-A1 Substituted Indole Compounds GRUENENTHAL GMBH (DE) 2010-09-02 — — US disclosed
US-20100222324-A1 Substituted Indole Compounds GRUENENTHAL GMBH (DE) 2010-09-02 — — US disclosed
WO-2010089127-A1 SUBSTITUTED SPIRO-AMIDES AS B1R MODULATORS Grünenthal GmbH (DE) 2010-08-12 — — WO disclosed
US-20100173889-A1 Substituted Pyrimidine and Triazine Compounds GRUENENTHAL GMBH (DE) 2010-07-08 — — US disclosed
US-20100173889-A1 Substituted Pyrimidine and Triazine Compounds GRUENENTHAL GMBH (DE) 2010-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222324-A1 Substituted Indole Compounds BDKRB1, BDKRB2, EDNRB ALDH1A1 1551/4885POLB 3754/4885HDAC11 1964/4885
US-20100173889-A1 Substituted Pyrimidine and Triazine Compounds ADORA2B, CCNB1, TYMS ALDH1A1 2375/4885POLB 98/4885HDAC11 1416/4885
US-20100234340-A1 Substituted Spiroamide Compounds BDKRB1, BDKRB2, AVPR1B ALDH1A1 1303/4885POLB 3022/4885HDAC11 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback